Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients

AIMS/INTRODUCTION: Weight reduction therapy is the primary treatment to prevent complications of obesity, such as lifestyle diseases and cardiovascular disease; however, to date, useful methods and genetic factors for predicting the outcomes of weight reduction therapy in obese patients have not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamakage, Hajime, Konishi, Yousuke, Muranaka, Kazuya, Hotta, Kikuko, Miyamoto, Yoshihiro, Morisaki, Hiroko, Morisaki, Takayuki, Satoh‐Asahara, Noriko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354504/
https://www.ncbi.nlm.nih.gov/pubmed/33400373
http://dx.doi.org/10.1111/jdi.13492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354504/
https://www.ncbi.nlm.nih.gov/pubmed/33400373
http://dx.doi.org/10.1111/jdi.13492

Ejemplares similares